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Abstract
Herpes simplex virus induces the activation of the cellular DNA double strand break response pathway dependent upon initiation of viral DNA
replication. The MRN complex, consisting of Mre11, Rad50 and Nbs1, is an essential component of the DNA double strand break response and
other reports have documented its presence at sites of viral DNA replication, interaction with ICP8 and its contribution to efficient viral DNA
replication. During our characterization of the DSB response following infection of normal human fibroblasts and telomerase-immortalized
keratinocytes, we observed the loss of Mre11 protein at late times following infection. The loss was not dependent upon ICP0, the proteasome or
lysosomal protease activity. Like activation of the DSB response pathway, Mre11 loss was prevented under conditions which inhibited viral DNA
replication. Analysis of a series of mutant viruses with defects in cleavage and packaging (UL6, UL15, UL17, UL25, UL28, UL32) of viral DNA
or in the maturational protease (UL26) failed to identify a viral gene product necessary for Mre11 loss. Inactivation of ATM, a key effector kinase
in the DNA double strand break response, had no effect on Mre11 loss and only a moderate effect on HSV yield. Finally, treatment of uninfected
cells with the topoisomerase I inhibitor camptothecin, to induce generation of free DNA ends, also resulted in Mre11 loss. These results suggest
that Mre11 loss following infection is caused by the generation of free DNA ends during or following viral DNA replication.
© 2007 Elsevier Inc. All rights reserved.Keywords: HSV; DNA damage response; Mrell; MRNIntroduction
Eukaryotic cells possess a DNA double strand break (DSB)
response in order to repair genomic damage suffered as a result
of exogenous insults, such as ionizing radiation, or for recov-
ering collapsed replication forks. The MRN complex, com-
posed of Mre11, Rad50 and Nbs1, is necessary for repair of
DSBs. This complex binds to and tethers together free DNA
ends and is capable of processing the ends for subsequent repair
steps (Hopfner et al., 2002; Paull and Gellert, 1998; Paull and
Gellert, 1999). Recently, evidence has emerged indicating that
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doi:10.1016/j.virol.2007.12.005activation of the PI(3)-like kinase ATM, which has long been
known to be central to the DSB response (Carson et al., 2003;
Lee and Paull, 2004; Lee and Paull, 2005; Paull and Lee, 2005).
Once ATM is activated, it phosphorylates and activates many
substrates including itself, Nbs1, H2A.X, Brca1, p53, 53bp1,
Chk2 and other proteins, to facilitate repair, activate cell cycle
checkpoints and even induce apoptosis (Burma et al., 2001;
Kastan and Lim, 2000; Rappold et al., 2001).
The actual repair of DSBs occurs primarily via two mutually
exclusive mechanisms. In mammals, non-homologous end join-
ing (NHEJ) is the most common mechanism. NHEJ utilizes
DNA-PKcs, Ku and the XCRR4/Ligase IV complex to religate
the two broken ends and thus is error prone as any genetic
changes are not corrected (Pastwa and Blasiak, 2003). Homo-
logous recombination (HR) is the common mechanism in yeast
and during S-phase of mammalian cells. HR utilizes RPA and
the Rad51 epistasis group to repair the DSB based on a homo-
logous DNA template and thus, unlike NHEJ, can correct ge-
netic changes (Wyman et al., 2004).
Fig. 1. TheDSB response is activated andMre11 is lost followingHSVinfection.
HFK monolayers were infected at MOI=10 and harvested at the indicated hours
post infection (h pi). Following SDS–PAGE and transfer to membranes, whole
cell lysates were probed for cellular components of the DNA DSB response and
viral proteins by Western blot. The arrow head indicates the position of pATM.
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their host cell during infection. Simian virus 40 (SV40) large T
antigen (LT) interacts with p53, countering activation of cell
cycle checkpoint and apoptosis pathways, and with the MRN
complex, preventing DSB detection (Bargonetti et al., 1992;
Digweed et al., 2002; Lanson et al., 2000). SV40 LT also
interacts directly with Nbs1 to suppress a block to viral DNA re-
replication normally imposed by Nbs1 (Wu et al., 2004). Ade-
novirus also interferes with the actions of p53 and the MRN
complex, though in this case it is by causing their degradation.
Loss of p53 and the MRN complex prevents apoptosis and
protects progeny adenovirus genomes from concatemerization
respectively (Moore et al., 1996; Querido et al., 1997; Stracker
et al., 2002). The gamma herpesvirus Epstein–Barr virus (EBV)
also inhibits p53 and activates E2F-1, cyclin E and Cdc25A to
promote cell cycle progression, countering the cell cycle check-
point branch of the DSB response (Mauser et al., 2002a,b).
However, EBV infection also causes activation of ATM and its
downstream components involved in repair. In fact, ATM and
the MRN complex localized to sites of EBV DNA replication,
a pattern that is also seen with herpes simplex virus type 1
(HSV-1) (Kudoh et al., 2005).
HSV-1 is an alpha herpesvirus that encodes seven essential
DNA replication proteins including viral polymerase (UL30),
origin binding protein (UL9), single-stranded DNA binding
protein (ICP8), helicase-primase components (UL5, UL8 and
UL52) and viral processivity factor (UL42) (Roizman and
Knipe, 2001). A growing body of evidence suggests that viral
DNA replication not only involves homologous recombination,
but also utilizes components of the host DSB response (Wil-
kinson and Weller, 2003). During HSV-1 infection, ATM and
many of its targets are activated dependent upon viral DNA
replication (Lilley et al., 2005; Shirata et al., 2005; Wilkinson
and Weller, 2004). ATM, the MRN complex, RPA, Rad51 and
p53 all localize to replication compartments and/or directly
interact with ICP8 (Lilley et al., 2005; Shirata et al., 2005;
Taylor and Knipe, 2004; Wilkinson and Weller, 2004). The
importance of these components for HSV-1 replication has been
established by using deficient cell lines. For example, ATM,
Nbs1 or Mre11 deficient cell lines fail to support efficient viral
replication at least at the stage of viral DNA replication (Lilley
et al., 2005). Cells deficient for the recombination components
WRN and BLM also less efficiently support viral replication,
while cells deficient for Ku, a necessary component for NHEJ,
allow for greater efficiency of viral replication (Taylor and
Knipe, 2004). Also, consistent with these findings, DNA-PKcs,
a component of NHEJ, has long been known to be targeted to
the proteasome by the viral immediate-early (IE) protein
ICP0 (Lees-Miller et al., 1996; Parkinson et al., 1999). These
data suggest a dichotomy for DSB repair during HSV-1
infection in which HR and the prior detection and signaling
events are necessary for HSV-1 DNA replication, while NHEJ
appears detrimental to HSV-1, though at which stage of infec-
tion is unknown.
Previous reports characterizing the DSB response following
HSV-1 infection focused on models involving tumor derived or
non-human primate cell lines (Lilley et al., 2005; Wilkinson andWeller, 2004). We initiated the present study of the DSB res-
ponse following HSV-1 infection in non-tumor-derived cells of
human origin, believing that these cell types would be capable
of responding to the presence of viral DNA in a way most
closely corresponding to the situation in the infected host. Our
characterization of the DSB response following HSV-1 infec-
tion in telomerase-immortalized human foreskin keratinocytes
(HFKs) and human embryonic fibroblasts (HELs) confirms
previous results regarding activation of ATM and its targets.
However, we consistently observed loss of Mre11 following
HSV-1 infection, which has not been previously reported.
Results
DSB response and Mre11 loss following HSV-1 infection
Initially we sought to determine the status of the DSB res-
ponse components following HSV infection. Replicate mono-
layers of HFK cells (Fig. 1) were infected with wild type HSV-1
at MOI=10 and harvested at the indicated times. Lysates were
analyzed by Western blot for viral and host DSB response
proteins. The IE protein ICP0 was detectable by 1 h pi (lane 3)
and increased until 2 h pi (lane 5), after which its signal remai-
ned unchanged. The early (E) protein ICP8 was detectable by
2 h pi (lane 5) and its signal reached a steady level by 4 h
(lane 6). By 4 h pi, the late (L) proteins VP16 (not shown) and
gC, which are dependent upon DNA replication for expression,
could be detected and increased in signal intensity until at least
8 h pi. This pattern suggests that viral DNA replication began
sometime after 2 h and before 4 h pi under these conditions.
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response proteins ATM and Nbs1 (lanes 5–6) as indicated by
the reaction of phospho-specific antibodies and mobility shift
of total Nbs1. Others have reported that such activation was
dependent upon viral DNA replication (Lilley et al., 2005;
Shirata et al., 2005; Wilkinson and Weller, 2004). Activated
Chk2, however, was detected as early as 1.5 h pi. Chk2 acti-
vation preceding detectable activation of other DSB response
components following HSV-1 infection was also reported by
Lilley et al. and possibly indicates a limited amount of viral
DNA replication at this earlier time (Lilley et al., 2005). We
also observed loss of DNA-PKcs following infection in HFKs.
The loss began as early as 1 h pi, though complete loss did not
occur until after 2 h pi (lanes 5–6). Total levels of Rad50 did
not significantly change following infection in HFKs, similar
to previous reports of other cell types, allowing it to act as a
loading control (Lilley et al., 2005; Shirata et al., 2005;
Wilkinson and Weller, 2004). Gel conditions that resulted in a
visible shift of total Nbs1 following infection also resulted inFig. 2. Mre11 and Nbs1 localize to sites of viral DNA replication. A–H: HFK cells s
between 2 and 8 h pi. Immunofluorescence was performed as described in Material
indicated by the ICP8 immunofluorescence pattern and are not indicative of specific ti
to immunofluorescence. The arrow in panel I indicates an HSV infected cell contai
contain no detectable Mre11.some apparent reduction in signal. Gel conditions that resulted
in less or no total Nbs1 shift did not result in this reduction. The
apparent reduction in the former case is thus likely due to
the dispersal of signal and not loss of Nbs1 protein. Essentially
identical results were obtained using HEL cells (data not
shown).
Mre11 levels were also reported to be unchanged following
HSV-1 infection (Lilley et al., 2005; Shirata et al., 2005; Wil-
kinson and Weller, 2004). However, we observed a sharp de-
cline in Mre11 accumulation between 2 and 4 h pi in both HFK
and HEL cells. Due to the temporal resolution of this exper-
iment, we were unable to determine whether Mre11 loss coin-
cided with, or was preceded by gC accumulation, a surrogate for
viral DNA replication. However, as Mre11 is necessary for
efficient viral DNA replication, the latter explanation is more
likely (Lilley et al., 2005).
By indirect immunofluorescence microscopy (IF), all three
MRN components have been localized at sites of HSV DNA
replication (Lilley et al., 2005; Shirata et al., 2005; Taylor andeeded onto glass coverslips were infected at MOI=0.01 and fixed various times
s and methods. Images of cells are ordered to depict progression of infection as
mes. I and J: HFKs were infected as in panels A−H, fixed at 48 h pi and subjected
ning Nbs1, while the arrow heads in panel J point to HSV infected cells which
Table 2
Mre11 is lost at late times following HSV infection
Staining pattern 24 h pi 48 h pi
ICP8−/Mre11− 19 (12.2%) 18 (17.5%)
ICP8−/Mre11+ 110 (70.5%) 61 (59.2%)
ICP8+/Mre11− 13 (8.3%) 17 (16.5%)
ICP8+/Mre11+ 14 (9.0%) 7 (6.8%)
Cells in digital images from the experiment described in Fig. 2I were
enumerated for their pattern of Mre11 and ICP8 staining.
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Mre11 and Nbs1 behaved in our cell culture system, we infected
either HFK or HEL cells at MOI=0.01 and fixed cells at various
times post infection up to 8 h then immuno-stained for either
Mre11 or Nbs1 and for ICP8, and both were visualized by
confocal microscopy (Figs. 2A−H). Using a lowMOI, we could
observe several stages of infection as judged by ICP8 staining
patterns (diffuse, punctuate, small and large globular, fully
expanded) (Quinlan et al., 1984). Images of fields of cells were
captured at different times post infection and cells displaying
ICP8 staining were categorized, as summarized in Table 1. At
4 h pi, 89% of ICP8 staining cells displayed diffuse or punctate
staining, while the proportion of cells displaying globular or
fully expanded ICP8 staining increased from 11% at 4 h to 58%
by 8 h. Mre11 and Nbs1 were both localized diffusely through-
out the nucleus with nucleolus exclusion in uninfected cells
(Figs. 2A−C, E−G). Early during infection, prior to detection of
ICP8 or when ICP8 was diffuse, Mre11 and Nbs1 localization
was indistinguishable from uninfected cells (Figs. 2A and E).
However, once ICP8 became punctuate or globular, indicating
localization to prereplicative sites and then replication compart-
ments, these proteins became enriched co-locally with ICP8,
indicating their presence at prereplicative sites and in replication
compartments (Figs. 2B−D, F−H). Staining levels for Mre11
did not appear to change during these times.
When we allowed the infection to proceed for 24 h (not
shown) or 48 h, we detected cells with bright ICP8 staining
throughout the nucleus but with little or no Mre11 staining
(Fig. 2J). In contrast, Nbs1 staining persisted at these late times
in cells with bright ICP8 staining (Fig. 2I). Results from quan-
tification of ICP8/Mre11 staining patterns at 24 and 48 h pi are
shown in Table 2. A majority of cells were uninfected in that
they displayed no ICP8 staining. Cells infected with HSV-1
(displaying ICP8 immunofluorescence) but with no detectable
Mre11 increase from ~8.3% at 24 h, to 16.5% at 48 h of the total
cells counted or from 48.1% to 70.8% of only infected cells.
The fraction of cells displaying both types of immunofluores-
cence decreased between these two time points. We speculate
that cells displaying both ICP8 and Mre11 staining are at a stage
of the viral replication cycle exemplified in Figs. 2D and H and
may have resulted from secondary infections. These data
support the Western blot results in Fig. 1 in suggesting that
Mre11 is lost following viral DNA replication. The discrepancy
in times at which Mre11 is lost is likely due to the differences in
MOI used in the two types of experiments.Table 1
Summary of ICP8 staining patterns between 4 and 8 h post infection
ICP8 staining pattern 4 h pi 6 h pi 8 h pi
Diffuse 2 (22%) 3 (27%) 6 (23%)
Punctate 6 (67%) 3 (27%) 5 (19%)
Globular (small) 1 (11%) 2 (18%) 2 (8%)
Globular (large) 0 3 (27%) 4 (15%)
Fully expanded 0 0 9 (35%)
Total 9 11 26
Cells in digital images represented in Figs. 2A–H were enumerated for their
pattern of ICP8 staining.ICP0, the proteasome and the lysosome are unnecessary for
Mre11 loss
The two principal mechanisms for protein degradation in cells
involve either the proteosome or the lysosome (Ciechanover,
2006). We first investigated whether Mre11 loss was through an
ICP0-dependent mechanism. ICP0 possesses E3 ubiquitin ligase
activity and has been demonstrated to cause the proteasome-
dependent degradation ofmany cellular proteins, includingDNA-
PKcs, CENP-A, CENP-C, PMS Sp100, and cdc34 (Chelbi-Alix
and de The, 1999; Everett et al., 1999; Lomonte et al., 2001;
Parkinson et al., 1999; Hagglund and Roizman, 2003). Though
these targets of ICP0 are degraded early during infection, ICP0 is
present throughout the course of infection allowing for the
possibility that it may target Mre11 for degradation late during
infection. To test whether ICP0 was necessary for Mre11 loss,
HFKs were infected with either wild type HSV-1 or the ICP0
mutant 7134 at variousMOIs. At 16 h pi, the cells were harvested
and lysates analyzed by Western blot (Fig. 3A).
Following infection of human fibroblasts at low MOI, ICP0
mutants are severely restricted in the expression of other viral
genes (Everett et al., 2004). To confirm that any phenotype we
observed was not the result of low MOI we compared gene
expression in HFKs between wt HSV-1 and 7134. Regardless of
MOI we observed no significant difference, indicating that all
the MOIs used were above the threshold of this restriction. As
expected, 7134 failed to express ICP0 and thus did not cause
DNA-PKcs degradation (lanes 5–7). However, the absence of
ICP0 had no discernable effect upon either activation of Nbs1
(pNbs1) or Mre11 loss. In order to determine whether the
absence of ICP0 had any effect on an ATM target other than
Nbs1, we also determined that infection with 7134 resulted in
only slightly reduced levels of phosphorylated Chk2, as com-
pared to wt virus infection. We observed similar results with
HEL fibroblasts (data not shown). These data indicate that ICP0
is not required for Mre11 loss following HSV-1 infection or for
activation of ATM or its targets Nbs1 and Chk2.
The possibility remained that Mre11 was being degraded
by the proteasome due to the actions of other viral or cellular
proteins. To determine if Mre11 loss was mediated by the
proteasome, we infected replicate HFK monolayers with wt
HSV-1 in the presence or absence of MG132, a peptide alde-
hyde inhibitor of the 26S proteasome. Cells were harvested
at 8 h pi and lysates analyzed by Western blot (Fig. 3B).
Treatment with MG132 protected DNA-PKcs from degradation
(lanes 3−6). Activation of Nbs1 and levels of viral proteins were
slightly reduced by treatment with MG132. This was expected
Fig. 3. Mre11 loss does not require ICP0 or the activities of the proteosome or
lysosome. A: HFK monolayers were infected with wt HSV-1 or the ICP0
deficient virus 7134 at the indicated MOIs and harvested at 8 h pi. Following
SDS–PAGE and transfer to membranes, whole cell lysates were assayed for
cellular and viral proteins by Western blot. B and C: HFK monolayers were
infected with wt virus and overlaid with media with or without the proteosome
inhibitor MG132 (0, 10 or 20 μM) or the inhibitor of lysosomal proteases
ammonium chloride (0, 10 or 20 mM) at 1 h pi. Following SDS–PAGE and
transfer to membranes, whole cell lysates were assayed by Western blot for
cellular and viral proteins. Asterisks in panel B indicate the altered mobility of
Nbs1 following phosphorylation.
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of HSV infection (Everett et al., 1998). Following HSV
infection Mre11 levels were minimally affected by MG132
treatment (compare lane 2 to lanes 4 and 6). While some Mre11
was retained following MG132 treatment, comparison with
DNA-PKcs protection clearly indicated that Mre11 loss was
largely due to mechanisms other than proteasome-dependent
degradation. As MG132 is also reported to inhibit the cytosol-
localized calpains and lysosomal-localized cathepsins (Lee and
Goldberg, 1998; Rock et al., 1994), these proteases are likely
not involved in Mre11 loss.
To further determine if lysosomal proteases were involved in
Mre11 loss, replicate HFK monolayers were infected and after
1 h, allowing for absorption and release of capsids from endo-
somes, treated with ammonium chloride, a well-established
lysomotropic inhibitor of lysosomal proteases (Fuertes et al.,
2003). The cells were harvested at 8 h pi and lysates subjected to
Western blot analysis (Fig. 3C). We observed no change in
Mre11 loss with 10 or 20 mM ammonium chloride treatment.
These concentrations were sufficient to prevent productive in-
fection when present at the time of infection (data not shown).
These data indicate that Mre11 loss is not mediated by lyso-
somal degradation.
Mre11 stability and the requirement of de novo gene expression
HSV-1 infection inhibits host gene expression, which would
be expected to result in loss of unstable proteins as they turn
over and are no longer replenished. To test whether this was
the case with Mre11, we infected keratinocytes (data not shown)
or HEL fibroblasts in the presence or absence of actinomycin D
or cycloheximide to inhibit mRNA or protein synthesis res-
pectively. Cells were harvested at 16 h pi and the lysates
analyzed by Western blot (Fig. 4). Treatment with either drug
prevented viral gene expression, as indicated by the lack of
detectable ICP0 (compare lanes 2, 4 and 6). Some gC was
detected following drug treatment, likely from input virions.
Drug treatments did result in a slight reduction of Mre11 in both
infected and uninfected cells. However, HSV-1 infection aloneFig. 4. Activation of the DSB response and Mre11 loss following infection
require de novo gene expression. HEL monolayers were infected at an MOI of
20 in the presence or absence of 5 μM actinomycin D (ActD) or 10 μg/mL
cycloheximide (CHX). Following SDS–PAGE and transfer to membranes,
whole cell lysates were assayed for components of the MRN complex or viral
proteins by Western blot. Since we have never observed a change in the level of
Rad50 following infection, it was used as a loading control. M: mock infected.
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that the majority of loss was not due to protein instability.
These data also indicate that de novo viral gene expression is
needed for Mre11 loss, consistent with the observed kinetics in
Fig. 1.
Mre11 loss is dependent upon a late event in the viral
replication cycle
Our initial Western blot analysis (Fig. 1) suggested the action
of either early or late viral functions as the effectors of Mre11
loss. In order to differentiate between early and late functions,
we used various mutants to halt infection at specific stages of
gene expression. Mutants which fail to express either ICP4
(n12) or ICP27 (d27) are impaired in early and late gene
expression (Roizman and Knipe, 2001). Infecting either HFK or
HEL monolayers with these viruses did not result in Mre11 loss
(Fig. 5, compare lane 2 with lanes 6 and 7, and lanes 9 and 13).
As expected the amount of ICP8 was reduced following infec-
tion with n12 (lanes 6 and 13), while d27 infection resulted in
levels equivalent to wt (lane 7). We detected gC, though mini-
mal amounts are likely the contribution of input virions (see
below). No ICP4 or ICP27 was detected in the lysates of their
respective mutants, confirming their genotype. These data
indicate that Mre11 loss requires ICP4 and ICP27 as well as the
expression of one or more early or late proteins dependent upon
ICP4 and ICP27.
To allow E gene expression, but prevent L gene expression,
we infected cells with mutants deficient in ICP8 (d301) or viral
DNA polymerase (HP66), or with wt virus in the presence of
PAA. These conditions prevent viral DNA replication and thus
prevent true-late gene expression. HFK or HEL monolayers
infected with the two mutants exhibited gC amounts above that
of n12 (compare lanes 4, 5 and 6, and lanes 11, 12 and 13),
though reduced in comparison to wt infection, while PAAFig. 5. DSB response activation and Mre11 loss require viral DNA replication.
HEL monolayers were infected with wt virus in the presence or absence of
400 μg/mL PAA or infected with the mutants deficient in ICP8 (d301, 8−),
polymerase (HP66, pol−), ICP4 (n12, 4−) or ICP27 (d27-1, 27−). Following
SDS–PAGE and transfer to membranes, whole cell lysates were assayed for
cellular or viral proteins by Western blot. M: mock infected.treatment resulted in gC levels equivalent to that seen with n12
(compare lanes 3 and 6, and 10 and 13). The increased gC levels
observed during d301 and HP66 infection are likely due to
increased particle to pfu ratios in these stocks. The pattern of
accumulation of US11, whose de novo synthesis is also depen-
dent on DNA replication, was consistent with this interpreta-
tion, since under conditions where DNA replication was
blocked (lanes 3–7) its accumulation was vastly decreased. IE
and E gene expression was largely unaffected as demonstrated
by ICP4, ICP0, ICP27 and ICP8. We did not observe Nbs1
activation under conditions which prevented viral DNA repli-
cation, in contrast to previous reports that observed activation of
ATM and Nbs1 following HSV infection in the presence of PAA
or acyclovir (another inhibitor of viral DNA replication), though
not following HP66 infection (Lilley et al., 2005; Shirata et al.,
2005; Wilkinson and Weller, 2004). We did not observe Mre11
loss under these conditions, suggesting that viral DNA repli-
cation and/or L gene expression are necessary for its loss.
Analysis of late mutants for Mre11 loss
Because Mre11 loss did not occur in the absence of viral
DNA replication and late gene expression, we decided to survey
viruses deficient in the expression of various late genes for their
ability to cause Mre11 loss. We reasoned that any benefit to
HSV replication due to Mre11 loss was likely due to preventing
detection and subsequent repair of free DNA ends at late times
of infection, generated through the processing and packaging of
progeny genomes. Thus, we chose to test mutants that have
been characterized as deficient in proper processing and pack-
aging of progeny genomes. Mutants viruses individually de-
leted for UL6 (hr74), UL15 (hr81-1), UL17 (dUL17), UL25
(kUL25), UL28 (gCB) and UL32 (hr64) were tested for Mre11
loss following infection (Addison et al., 1990; Baines et al.,
1994; Poon and Roizman, 1993; Salmon et al., 1998; Schaffer
et al., 1974; Sherman and Bachenheimer, 1987, 1988). Briefly,
UL6 encodes the portal protein through which DNA enters the
capsid (Newcomb et al., 2001); UL15 and UL28 gene products
are components of the terminase (Adelman et al., 2001; Yu and
Weller, 1998); UL25 gene product is necessary for stabilizing
encapsidated DNA and late stages of capsid maturation (McNab
et al., 1998; Stow, 2001); and UL17 (a tegument component)
and UL32 de novo expression is necessary for correct local-
ization of preformed capsids to sites of DNA packaging (Lam-
berti and Weller, 1998; Taus et al., 1998).
We infected keratinocytes (Fig. 6A) and HEL fibroblasts
(data not shown) with these mutants and harvested at 8 h pi
to evaluate Mre11 loss. We noted that the UL15 and UL17
(lanes 3 and 6) mutants consistently, and UL6 mutant occa-
sionally (lane 4), showed less Mre11 loss than wt virus. How-
ever, further analysis of the lysates revealed markedly reduced
levels of selected viral proteins ICP0, ICP8, the γ1 protein
VP16 and the γ2 proteins gC and US11. This defect has been
previously seen for these mutants and contributed to a high
complementation index when titers were determined on compli-
menting cell lines (personal communication, S. Weller and
J. Baines). These mutants also exhibited reduced activation of
Fig. 6. Infection with HSV-1 processing and packaging mutants supports Mre11
loss. A and B: HFK monolayers were infected with wt virus or the indicated
mutants characterized for defects in processing and packaging of viral DNA (see
Results for description of mutants). C: HFK monolayers were infected with wt
HSVor two mutants defective for the viral encoded protease UL26. Cells were
infected at MOI=20 (A and C) or 200 (B). Following SDS–PAGE and transfer
to membranes, whole cell lysates were analyzed for cellular and viral proteins by
Western blot.
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could not determine whether the failure to cause Mre11 loss was
due to the specific loss of the viral genes or due to the general
replication defect. The absence of detectable gC in the lysate
from cells infected with the UL28 mutant gCB is consistent with
the genotype of the parental virus HSV-1 KOSΔ2, which con-
tains a deletion from −569 to +124 of the gC gene (Tengelsen
et al., 1993).In order to overcome this defect in general viral fitness for
the viral mutants hr81-1, hr74 and dUL17, we repeated infec-
tions at MOI=200 (Fig. 6B). At this MOI, viral protein levels
in the mutant infected cells were equal to or in excess of that of
wt virus at MOI=20, and Nbs1 activation was also equivalent
to wt infected cells. However, under these conditions we no
longer saw any defect in Mre11 loss. Because of the high input
multiplicity used in this experiment we likely delivered large
amounts of UL17 and UL6 to infected cells. Thus our minimal
interpretation of these results would be that de novo expressed
UL15, UL6 and UL17 proteins are unnecessary for Mre11 loss.
Another candidate late function, which conceivably could
directly target Mre11, is the viral protease encoded by UL26. To
determine if UL26 was necessary for Mre11 loss, we infected
HFK cells with UL26dZ, a mutant with a deletion of the entire
UL26 ORF, or UL26H61E, a point mutant disabling the pro-
teolytic activity of the viral protease (Desai et al., 1994). At an
MOI of 20, these mutants had no defect in Mre11 loss or viral
protein accumulation (Fig. 6C). This result suggests that the
viral maturational protease does not contribute to loss of Mre11.
Importance of the DSB response for HSV replication
Previous reports on the importance of ATM in HSV infection
are contradictory. Lilley et al. reported that fibroblasts from
ataxia telangiectasia (AT) patients and cells treated with caf-
feine, which inhibits ATM activity, do not support efficient viral
replication (Lilley et al., 2005). Shirata et al. also showed that
AT fibroblasts were unable to support efficient viral replication.
However, using siRNA knockdown of ATM in 293T cells, they
found no defect in viral replication (Shirata et al., 2005). To
elucidate ATM's importance to HSV replication and determine
if activation of ATM's targets is necessary for Mre11 loss,
replicate cultures of HFKs were infected and either left un-
treated or treated with caffeine or KU-55933 (ATMi), a specific
inhibitor of ATM (Hickson et al., 2004). Cells were harvested
at 8 h pi for Western blotting (Fig. 7) or at 24 h pi for virus yield
or quantification of viral DNA by real time PCR (Table 3).
Western blot analysis showed that while both caffeine and
ATMi inhibited Nbs1 phosphorylation by ATM, ATMi was
more effective. Also, while caffeine greatly reduced gC levels,
ATMi had no effect. Neither prevented Mre11 loss, indicating
that the loss was not dependent upon events downstream of
ATM in the DSB response. Caffeine treatment also resulted in a
~30% reduction in viral genome copy number and a 10 to 38
fold reduction in virus yield while ATMi treatment had no effect
on genome copy number and only caused up to a 4 fold reduc-
tion in yield. These results suggest that caffeine's effects on
HSV infection are largely due to activities other than ATM
inhibition and that while ATM activation does contribute to
HSV replication, it is not essential.
Camptothecin causes Mre11 loss
Since none of the mutants deficient in expression of proteins
involved in assembly, DNA cleavage or DNA packaging that
we tested were defective in Mre11 loss, we considered the
Fig. 8. Camptothecin induces Mre11 loss in uninfected cells. HEL monolayers
were growth arrested by contact inhibition and serum starvation for 3 days. Cells
were replated 1:2 into complete growth medium. Twenty hours following
release from arrest, cells were treated with 1 μM camptothecin (CPT) or 5 μg/
mL actinomycin D (ActD) for 4 h. Following SDS–PAGE and transfer to
membranes, whole cell lysates were assayed for Rad50, Mre11 and tubulin by
Western blot.
Fig. 7. ATM activation is not required for Mre11 loss or late gene expression.
HEL monolayers were infected in the presence or absence of the ATM inhibitors
caffeine (Caff, 5 mM) or KU-55933 (ATMi, 10 μM) in duplicate and harvested
at 8 h pi. Following SDS–PAGE and transfer to membranes, whole cell lysates
were assayed for Mre11, pNBS1, ICP8 and gC by Western blot. The bottom
panel is a protein loading control showing the Ponceau S stain of the transfer
filter; arrows indicate the position of molecular weight markers.
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Mre11 loss. In this model, activation of the DSB response
would lead to Mre11 degradation, perhaps as part of a negative
feedback loop. Inhibition of ATM and thus the DSB response
downstream of ATM did not affect Mre11 loss (Fig. 7). Because
Mre11 is upstream of ATM, engagement of DNA ends by the
MRN complex might be sufficient to cause Mre11 loss, and we
would expect this to occur outside the context of HSV infection.
To test if this was the case, cells were treated with camptothecin
(CPT), which generates free DNA ends and activation of the
DSB response in S-phase cells due to the inhibition of topo-
isomerase I. Because CPT primarily functions in S-phase,
confluent cultures of HEL cells were serum-starved and then
released from quiescence by replating in medium with serum.
After allowing 20 h for the cells to reenter the cell cycle and to
enrich for S-phase cells (Ehmann, 2001), replicate cultures wereTable 3
ATM activity is not essential for viral replication
Yield Fold reduction DNA copy
Experiment 1
KOS 5.67×107 1
KOS+Caff 1.50×106 37.8 0.60
KOS+ATMi 1.93×107 2.9 1.1
Experiment 2
KOS 8.50×107 1
KOS+Caff 8.33×106 10.2 0.74
KOS+ATMi 2.17×107 3.9 1.1
HELs were infected in the presence or absence of caffeine (Caff) or KU-55933
(ATMi) and harvested at 24 h pi. Parallel samples were assayed for viral yield or
viral DNA copy number as described in the Materials and methods.treated with CPT and/or ActD. This transcription inhibitor was
used to control for differences in levels of gene expression due
to differential cell growth. After 4 h of treatment, cells were
harvested and lysates subjected to Western blotting (Fig. 8).
Rad50 and tubulin levels were not significantly affected by
ActD treatment, with or without CPT, in comparison to untreat-
ed cells. CPT treatment with or without ActD resulted in a
pronounced reduction in Mre11 levels. We did not observe any
cytopathology, likely ruling out apoptosis as an explanation for
the reduction in Mre11 in CPT treated cells (data not shown).
Discussion
Recent studies have characterized the activation of host cell
DNA damage response machinery following HSV-1 infection
(Lilley et al., 2005; Shirata et al., 2005; Wilkinson and Weller,
2004, 2006). In this study we observed DSB response activation
in telomerase-immortalized human keratinocytes (HFK) and
normal human diploid fibroblasts (HEL) consistent with pre-
vious reports using other cell types. However, our characteriza-
tion of host cell machinery led to the novel observation of
Mre11 loss at late times during infection. Other viruses, such
as adenovirus and SV40, are known to interfere with the MRN
complex, of which Mre11 is a part, in order to counteract
detrimental effects to viral replication (Digweed et al., 2002;
Stracker et al., 2002). We wished to further characterize Mre11
loss and DSB response activation in our system.
DSB response
We observed that the DSB response was activated following
HSV infection. Our characterizations are mostly in keeping with
those reported by others (Lilley et al., 2005; Shirata et al., 2005;
Wilkinson and Weller, 2004). Most evidence suggests that
activation of the DSB response is tied closely to viral DNA
replication. While input viral genomes are linear, and thus
potentially recognizable by the DSB response machinery, there
is no evidence that they activate a large scale DSB response.
Infection with UV inactivated virus or wt virus in the presence
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vation of the DSB response (Shirata et al., 2005). We also
observed that input virus alone in the absence of gene expres-
sion, due to treatment with actinomycin D or cycloheximide,
was insufficient to trigger this activation. Interference with viral
DNA replication also hinders activation of the DSB response.
Lilley et al. reported that PAA treatment did inhibit activation of
the DSB response following HSV infection at low, but not high
MOIs (Lilley et al., 2005). Shirata et al. confirmed this result
and also demonstrated that acyclovir was able to interfere with
the DSB response (Shirata et al., 2005). Wilkinson and Weller
(2004) also saw no activation following HP66 (pol−) infection.
We observed that activation required viral DNA replication and/
or late gene expression, as it was inhibited or absent in the
presence of PAA or following infection with mutants incapable
of viral DNA replication. These reports, and that of Taylor
and Knipe (2004), also demonstrated that DSB components
localize to sites of viral DNA replication and that ATM and
Nbs1 at these sites are activated. Taken together, these results
indicate that viral DNA replication triggers activation of the
DSB response.
One discrepancy between our results and those of others was
the effect of PAA on inhibition of the DNA damage response.
We used a relatively high MOI in our experiments, which,
according to Lilley et al. (2005) and Shirata et al. (2005) should
have been refractory to PAA's effects on Nbs1 activation. One
possible reason that PAA, and also acyclovir, do not always
inhibit activation of the DSB response is that, depending upon
the exact conditions, these drugs may allow some limited DNA
replication. Another possibility is the activation of a separate
DNA damage response, as detailed by Wilkinson and Weller
(2004). There were also virus strain differences between our
study and others, which might affect either the extent of viral
DNA replication following drug treatment, or the activation of a
DNA damage response. We used gC as a surrogate marker for
the onset of viral DNA replication. Wilkinson andWeller (2004)
used IF to visualize replication compartment formation, com-
paring ICP8 and RPA staining patterns.
While the DSB response is likely activated by viral DNA
replication, its importance to viral replication is still not under-
stood. Due to the localization of DSB machinery to replication
compartments, it has been proposed that it helps facilitate viral
DNA replication (Lilley et al., 2005; Shirata et al., 2005; Taylor
and Knipe, 2004; Wilkinson and Weller, 2004). This hypothesis
is supported by the results of Lilley et al. (2005) showing that
cells from A-TLD or AT patients, and thus deficient in Mre11 or
ATM respectively, fail to facilitate efficient viral replication
with over a log reduction in yield. Cells either treated with
caffeine, which results in failure to activate ATM, or expressing
adenovirus E1B and E4orf6 proteins, which results in MRN
complex degradation, also do not support efficient HSV repli-
cation, resulting in over a log reduction in yield (Lilley et al.,
2005). Mre11 deficient cells in particular were also impaired for
viral DNA replication. These results are called into question by
the report by Shirata et al. (2005). They also noted a deficiency
in viral replication at the level of viral E protein accumulation in
cells from AT or NBS (Nbs1 deficient) patients. However, if theDSB response primarily played a role in aiding viral DNA
replication, it should have only caused reductions in L protein
levels and not IE or E protein levels. These investigators also
went on to show that siRNA knockdown of ATM in 293T cells
had no effect on virus yield. It is unclear what differences there
might be in the cell types to account for the discrepant results.
It is possible that the presence of SV40 large T antigen is
disrupting the normal DSB response in 293 T cells, though
Shirata et al. (2005) demonstrated that it was intact following
irradiation.
In the human cell types that we investigated, it appears that
the DSB response, at least at the level of ATM activation, is not
essential for viral DNA replication and contributes only
moderately to virus replication. Because caffeine has targets
other than ATM, we also used the newly developed compound,
KU-55933, to specifically inhibit ATM activation (Hickson
et al., 2004). While caffeine did drastically reduce both viral
yield and DNA replication, ATMi had no effect on viral copy
number and only moderately reduced virus yield. Thus, caf-
feine's inhibitory effects on virus replication are likely due to
effects on targets other than ATM. How ATMi effected viral
replication is unclear as there also seemed to be no defect in L
gene expression or viral genome copy number. One possibility
is that failure to activate ATM interferes with proper assembly
or egress of progeny virions. Another explanation is that, while
viral DNA replication is able to produce equivalent genome
copies with or without ATM activity, its absence results in
defective genomes which are unable to contribute to infectious
progeny virus.
Inhibition of the MRN complex more severely affects viral
replication, indicating that it may have significance during
infection beyond simply activation ATM. It is very likely that
the MRN complex is necessary for viral DNA replication, as
suggested by results from the A-TLD and adenovirus protein
expressing cells (Lilley et al., 2005; Tauchi et al., 2002; Wil-
kinson and Weller, 2003; Yamaguchi-Iwai et al., 1999). Recom-
bination likely plays an important role in HSV replication
(Wilkinson and Weller, 2003). Taylor and Knipe have provided
evidence that cellular recombination machinery is important for
HSV replication since cells deficient for WRN, another protein
involved in recombination, are defective in supporting viral
replication and HSV specific recombination (Cheng et al., 2007;
Taylor and Knipe, 2004). The MRN complex is also necessary
for normal recombination and thus it is likely that the defects to
viral replication when the MRN complex is inhibited are due to
inhibition of recombination (Tauchi et al., 2002; Yamaguchi-
Iwai et al., 1999).
Mre11 loss
Mre11 loss following HSV infection would be expected to
adversely affect the ability of the cellular DSB response ma-
chinery to recognize and respond to DSBs. How this loss might
affect HSV replication is unclear. Here, we have shown that
Mre11 loss following HSV infection is a late event that is
dependent upon viral DNA replication and perhaps L gene
expression. Unlike many other cellular proteins that are lost
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dependent on ICP0 nor does it depend upon UL26, proteasomal
or lysosomal proteases. As these general degradation mechan-
isms appear not to be involved in Mre11 loss, the action of one
or more specific proteases is left as the most plausible mecha-
nism. It is also likely that Mre11 is not completely degraded, as
we do not also see significant loss of Rad50 or Nbs1. Normally
when one component of the MRN complex is degraded or not
produced, the levels of the other two components are greatly
decreased as well, likely due to complex dependent stability
(Fernet et al., 2005; Stracker et al., 2002; Zhong et al., 2005).
Alternatively, a viral protein may stabilize Rad50 and Nbs1 in
Mre11's absence.
Others have not reported that Mre11 is lost following
infection, though their experimental systems utilized different
cell types and/or virus strains (Lilley et al., 2005; Shirata et al.,
2005; Wilkinson and Weller, 2004). In our hands, we found that
Mre11 loss was dependent upon cell type as CV-1 cells did not
exhibit the phenotype (data not shown). The basis for the
differences between the cell types is unknown, though notably
the one cell type in which we observed no loss of Mre11 at all
was non-human primate derived, whereas all others tested were
of human origin. Further experiments may determine if this is a
human specific phenotype.
Our results suggest that either viral DNA replication or the
function of L genes triggers Mre11 loss following HSV infec-
tion. While we have shown a number of late gene functions to
be unnecessary for Mre11 loss, it remains possible that a func-
tional redundancy among those we tested or a function we have
not tested is responsible for Mre11 loss. If viral DNA replication
is the trigger of Mre11 loss, the precise mechanism of loss is
unclear. It is possible that viral DNA replication triggers an IE
or E protein to either directly or indirectly target Mre11, leading
to its degradation. We have already demonstrated that the most
likely candidate, ICP0, is not necessary for Mre11 loss and no
other IE or E proteins have characterized functions that would
implicate them in protein loss. The triggering by viral DNA
replication of a cellular protein to affect Mre11 loss is also
possible. As it is known that viral DNA replication does activate
some cellular stress pathways, such as the DSB response and
PKR, this is a reasonable possibility (Chou et al., 1995; Lilley
et al., 2005; Shirata et al., 2005; Wilkinson and Weller, 2004).
Also of note, in the switch from origin dependent stage I
replication to origin independent stage II replication, cathepsin
B cleaves OBP to yield OBPC-1 (Link et al., 2007). However, it
is unlikely that cathepsin B is responsible for Mre11 loss as it is
inhibited by MG132.
If activation of such stress pathways does lead to Mre11 loss,
we would expect their activation to lead to Mre11 loss out of the
context of infection. We found this was indeed the case for the
DSB response induced by camptothecin. This result may indi-
cate that the activation of the MRN complex by viral DNA
replication leads to Mre11 turnover as part of a normal cellular
negative feedback loop. However, as Mre11 loss still occurred
when ATM activation was inhibited, the mechanism would not
be dependent on effectors in the DSB response pathway down-
stream of ATM. The reduction in Mre11 following CPT treat-ment was less significant than that observed following HSV
infection. Nevertheless, this does indicate that activation of the
DSB response, or perhaps certain general cellular stresses, can
cause Mre11 turnover. We suspect that the loss of Mre11 was
less pronounced due to the fact that CPT treatment primarily
affects cells in S-phase. While our synchronization protocol
resulted in an enriched S-phase population, many cells were still
in G1/G0 by 20 h after release from serum starvation. As such, a
portion of the cells were unaffected by CPT treatment, thus
reducing the observable loss.
If Mre11 loss is simply a normal consequence of DSB
response activation, it may still effect viral replication. Its loss
could, as we originally hypothesized, prevent repair of free
DNA ends in the viral DNA resulting from processing and
packaging. However, given that Mre11 is likely important for
viral DNA replication (Lilley et al., 2005), its loss at a later stage
of infection may limit viral DNA replication. This modulation
might limit production of viable progeny virions and thus be
detrimental to viral replication.
Materials and methods
Cells and viruses
Telomerase-immortalized human foreskin keratinocytes
(HFKs) were a gift from Shannon Kenney (UNC-Chapel Hill)
with permission from A. J. Klingelhutz who derived the cell line
as previously described (Farwell et al., 2000). HFKs were
maintained in Keratinocyte-SFM from Gibco supplemented
with EGF and bovine pituitary extract. Diploid human em-
bryonic lung fibroblasts (HELs) were obtained from ATCC.
HELs were maintained in DMEM with 10% fetal calf serum,
1% glutamine and 1% penicillin/streptomycin.
HSV-1 strain KOS1.1 was used as our wild type virus. The
following mutants were also used: ICP8 mutant d301 (Gao and
Knipe, 1989) (David Knipe, Harvard Univ.); UL30 (polymer-
ase) mutant HP66 (Marcy et al., 1990) (Donald Coen, Harvard
Univ.); ICP0 null mutant 7134 (Cai and Schaffer, 1989) (Pris-
cilla Schaffer, Harvard Univ.); ICP4 mutant n12 (DeLuca and
Schaffer, 1988) (Neal DeLuca, Univ. of Pittsburgh); UL17
mutant ΔUL17 (Salmon et al., 1998) (Joel Baines, Cornell
Univ.); UL25 and UL28 mutants kUL25 (McNab et al., 1998)
and GCB (Tengelsen et al., 1993) (Fred Homa, Univ. of Pitts-
burgh); UL15, UL32 and UL6 mutants hr81-1 (Yu and Weller,
1998), hr64 (Lamberti and Weller, 1998) and hr74 (Lamberti
and Weller, 1996) (Sandy Weller, Univ. of Connecticut) and
UL26 mutants dZ and H61E (Desai et al., 1994) (Prashant
Desai, Johns Hopkins Univ.)
Antibodies
Monoclonal antibodies against Rad50 (13B3) and Mre11
(12D7) were purchased from Genetex, Inc. Monoclonal anti-
body against total Nbs1 (100–222) and polyclonal antibodies
against phospho-Nbs1 (pNbs1) (100–284) and phospho-ATM
(pATM) (100-307A2) were obtained from Novus Biologicals.
Monoclonal antibodies against ATM (05-513) and DNA-PKcs
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phospho-Chk2 (pChk2) (Thr68, 2661S) was purchased
from Cell Signaling. Monoclonal antibody against ICP0
(H1A027-100) was purchased from Virusys. Monoclonal anti-
bodies against ICP4 (1101) and ICP27 (H1113) were purchased
from Rumbaugh-Goodwin Institute. Polyclonal antibody
against ICP8 (3–83) was a gift from David Knipe. Polyclonal
antibody against gC (R47) was a gift from Gary Cohen and
Roselyn Eisenberg (University of Pennsylvania). Monoclonal
antibody against US11 was obtained from Bernard Roizman (U.
of Chicago). Polyclonal antibody against VP16 was purchased
from Clontech. Goat anti-rabbit and anti-mouse HRP-conju-
gated secondary antibodies were purchased from Amersham
Biosciences.
Infection and preparation of cell extracts
Near confluent or confluent monolayers seeded 1 to 2 days
previously were inoculated with virus at a multiplicity of infec-
tion (MOI) of 20 plaque forming units (pfu) calculated based on
titers corrected for the host cell lines (1 HEL/HFK pfu ~4 Vero
pfu), unless otherwise noted. Thirty minutes to 1 h following
inoculation, cells were overlaid with spent media or spent media
containing 400 μg/mL PAA (an inhibitor of herpesvirus DNA
polymerase), 10 μg/mL cycloheximide, 5 μg/mL actinomycin
D, 5 mM caffeine, 10 μMKU-55933, or ammonium chloride or
MG132 (Sigma) at the indicated concentrations. For camp-
tothecin treatment, drug was added to medium at a final con-
centration of 1 μM for 4 h prior to harvesting. HFK monolayers
were harvested by washing with cold PBS and then scraping
directly into 1× SDS sample buffer [3.85 mM Tris–base (pH
6.8), 9.1% β-mercaptoethanol, 1.82% SDS, 4.6% glycerol and
0.023% bromophenol blue (in 100% ethanol)] and boiling for
5 min. In the case of HEL cells, media from monolayers were
collected and the monolayers were treated with trypsin until the
cells detached. The cells were then suspended in PBS, com-
bined with the previously collected media and were pelleted and
washed once with PBS before addition of 1× SDS sample buffer
and boiling as above. All harvests were performed at 8 h post
infection (pi) unless otherwise stated.
Western blotting
Cell equivalent aliquots of whole cell lysates were sepa-
rated by SDS–PAGE and transferred to PolyScreen polyvinyl-
idene difluoride membranes (Perkin-Elmer Life Sciences).
Ponceau S (Sigma) was used to visualize total protein and
ensure no discrepancies in protein equivalences. Membranes
were blocked with 5% milk in TBST (150 mM NaCl, 20 mM
Tris [pH 7.6], 0.05% Tween 20) then washed and incubated
with appropriate primary antibodies followed by further
washing and incubating with the appropriate secondary anti-
body all in TBST. After final washing in TBST, signal was
detected using Perkin-Elmer Western Lightening substrate.
Multiple exposures were made on Kodak BMR film to ensure
that the linear range was obtained. Films were scanned and
digitalized using Adobe Photoshop.Immunofluorescence
Cells were seeded on glass coverslips and allowed to grow
until confluent. The monolayers were infected at low MOI (0.1
or 0.01). At the indicated times, cells were washed with PBS
then fixed with 5% paraformaldehyde in PBS for 10 min
followed by permeabilization with 1% Triton X-100 in PBS.
Cells were then incubated in blocking buffer (2.5% normal goat
serum, 2.5% normal horse serum and 1% gelatin in PBS) for at
least 30 min, probed with the indicated primary antibody and
then washed and probed with either Texas red conjugated anti-
rabbit, or FITC conjugated anti-mouse antibody (Santa Cruz),
all in blocking buffer. Primary antibodies were omitted for
control cells. Following final washing with PBS, the coverslips
were mounted and allowed to set before visualization with an
Olympus FV500 confocal laser scanning microscope.
Plaque assay
Virus was titered as described previously (Gregory et al.,
2004). Monolayers of cells in 60 mm or 100 mm dishes were
infected with HSV at MOI=5. Cells and medium were har-
vested at various times post infection and subjected to 4
freeze/thaw cycles in an ethanol and dry ice bath then 37 °C
water bath. Serial 10-fold dilutions of the lysates were assayed
in triplicate on monolayers of Vero or CV-1 cells in 12 well
dishes. After 1 h, monolayers were covered with DMEM-H
containing 2% bovine calf serum and 0.3% methylcellulose.
After 3 days of incubation at 37 °C, medium was aspirated
from the wells and plaques stained with 0.8% crystal violet in
50% ethanol.
Real time PCR
Cell monolayers were infected at MOI=5 as above and
then harvested using Promega Wizard SV Genomic DNA
Purification System to isolate cellular and viral DNA.
Primers against c-Myc (TCAAGAGGTGCCACGTCTCC,
TCTTGGCAGCAGGATAGTCCTT) and UL19 (AAACAT-
CGCTGCCT-GGAG, GGGGCGCTTAAACTGTACG) were
designed by Dirk Dittmer (UNC-Chapel Hill). DNA
and primers diluted 1:200 were mixed with SyberGreen and
run on an ABI prism 7000 for 40 cycles at 95 °C denaturing
for 30 min and 55 °C annealing and extension for 1 min. 7000
systems SDS software was used to collect cycle data. Fold
viral DNA copy was calculated based on dCt of UL19
normalized to the dCt of c-Myc.
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